For UK MedTech companies
Your competitors are visible to NHS buyers on LinkedIn. You are not.
Clinical directors, procurement leads, and private hospital managers are more active on LinkedIn than most medtech teams realise. If your digital presence is thin, you are not in the room when decisions begin to form.
Two minutes. Solva follows up with specific digital presence options.
- Low engagement rates on company social media posts, if any exist
- Sales teams reporting difficulty in securing initial meetings with key decision-makers
- Target buyers being unaware of the company's solutions or expertise during their research phase
- Competitors consistently appearing in search results and industry discussions where the company is absent
- Increased reliance on traditional, often less efficient, sales channels
- Longer sales cycles due to lack of pre-existing brand awareness and trust
- Reduced lead generation and conversion rates, impacting revenue growth
- Higher cost per acquisition (CPA) due to less effective marketing efforts
- Perception as an outdated or non-innovative company
- Lack of credibility and thought leadership in the MedTech space
No verified UK data available
Source: No verified UK data available
Frequently asked questions
Why does this problem persist?
NHS clinical directors, procurement leads, and private hospital managers are increasingly active on LinkedIn. MedTech companies that dismiss social media miss the opportunity to build brand awareness, share clinical evidence, and engage with the peer networks that influence purchasing decisions.
What is the cost of leaving it unaddressed?
No verified UK data available
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.